PrimeStore® MTM (Molecular Transport Medium) was designed and optimized for molecular testing, allowing pathogenic samples to be collected, transported, and processed safely and efficiently. During the SARS-CoV-2 pandemic, millions of tubes of PrimeStore® MTM were sold to clients around the world.
The molecular transport medium inactivates infectious biological pathogens, including viruses and gram-positive/negative bacteria, while preserving and stabilizing labile DNA and RNA for downstream molecular applications.
Viral transport media (VTM) were designed to transport intact samples to be cultured prior to the widespread use of molecular testing and contain ingredients that inhibit optimal molecular testing. In contrast, PrimeStore® MTM was invented and optimized specifically for molecular testing.
As the only FDA Class 2 cleared product for microbial nucleic acid storage and stabilization, hospitals and laboratories trust that PrimeStore® MTM provides safer and more reliable testing than UTM/VTM, saline, or research use only devices.
Laboratories have independently validated PrimeStore® MTM with a range of platforms such as Roche, Thermo Fisher, Abbott, Siemens, Luminex, Bio-Rad, PSS, Promega, and BioMerieux, as well as the Cepheid GeneXpert point of care platform.
A key feature of PrimeStore® MTM is that it allows lab teams to process multiple tests from a single sample that has been inactivated and stabilized in PrimeStore® MTM.
Multiple peer-reviewed scientific papers, dating from 2011 onwards, support the use of PrimeStore® MTM for pathogen detection from a wide range of clinical matrices and biofluid types collected and processed in different countries.